Načítá se...
The revolution of the anti-diabetic drugs in cardiology
Beginning in December 2008, under the auspices of Food and Drug Administration, numerous controlled clinical trial were planned, and in part completed, concerning the cardiovascular (CV) effects of hypoglycaemic drug in patients with Type 2 diabetes mellitus. At least 9 studies have been concluded,...
Uloženo v:
| Vydáno v: | Eur Heart J Suppl |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7270967/ https://ncbi.nlm.nih.gov/pubmed/32523463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa084 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|